MEDICEPTION recently completed the forecasting and detailed review on "Diabetes scenario in 2030". Diabetes is growing life-style diseases and having high mortality as co-morbidity with cardiac disorders. The pharma companies need a giant and collaborative effort to deal the situation, which is going to be real alrming in 2030.
MEDICEPTION recently produced the analysis of real patients data undergone valve replacement surgery. The analysis compared the choice of tissue vs mechanical valves; AVR vs MVR, and also the comparison of different vendors. This data will help cardiac surgeons to take decision on choice of valves with patient's history. This methodlogy can also be utilized by insurance companies to perform the their early evalaution of survival scores.